ArticleAmerican journal of preventive cardiology2026

Oral PCSK9 inhibitors for elevated LDL-C: A systematic review and meta-analysis of randomized trials.

Aditya Karthikeyan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.